Know What's Happening in BioTech

10 Companies Hiring IT Professionals Now
NewsJan 29, 2026

10 Companies Hiring IT Professionals Now

Biotech firms are aggressively recruiting IT talent as the sector’s digital transformation accelerates. After a mid‑year dip in 2025, job postings rebounded in the last four months and January 2026 listings already surpass December’s total. Ten companies—including AbbVie, Amgen, Lilly...

By BioSpace
Tunable Morphological Engineering of Self‐Assembled Copper‐Glutathione Nanoarchitectures: Size‐Dependent Antibacterial Action for Pathogen Infections Management
NewsJan 29, 2026

Tunable Morphological Engineering of Self‐Assembled Copper‐Glutathione Nanoarchitectures: Size‐Dependent Antibacterial Action for Pathogen Infections Management

Researchers have developed size‑tunable copper‑glutathione (Cu‑GSH) nanocapsules using a simple co‑precipitation method, enabling precise control over particle morphology. In kiwifruit trials, the optimized formulation delivered 77% therapeutic and 66% protective efficacy, outperforming conventional copper pesticides. Small spherical nanocapsules penetrated plant...

By Small (Wiley)
Ultrasensitive MicroRNA Detection Combining Reduced Graphene Oxide Electrolyte‐Gated Transistors and Machine Learning
NewsJan 29, 2026

Ultrasensitive MicroRNA Detection Combining Reduced Graphene Oxide Electrolyte‐Gated Transistors and Machine Learning

Researchers have created an ultrasensitive biosensor that merges DNA‑functionalized reduced graphene oxide (rGO) electrolyte‑gated transistors (EGTs) with machine‑learning analytics to detect cancer‑ and neuro‑related microRNAs. The platform targets the miR‑34 family and achieves a limit of detection as low as...

By Small (Wiley)
Sulfur‐Fumigation Engineered Ceria Nanoparticles With Augmented Oxygen Vacancies for Enhanced Therapy of Drug‐Induced Liver Injury
NewsJan 29, 2026

Sulfur‐Fumigation Engineered Ceria Nanoparticles With Augmented Oxygen Vacancies for Enhanced Therapy of Drug‐Induced Liver Injury

Researchers applied sulfur fumigation to reconfigure ceria nanoparticle surfaces, exposing (200) and (220) crystal facets and generating abundant oxygen vacancies. This structural shift dramatically boosts the particles’ reactive oxygen species (ROS) scavenging capability while maintaining a liver‑targeting hydrodynamic size (~136 nm)....

By Small (Wiley)
Tenpoint Gets FDA Nod for Presbyopia Eye Drop and $235M
NewsJan 29, 2026

Tenpoint Gets FDA Nod for Presbyopia Eye Drop and $235M

Tenpoint Therapeutics received FDA approval for its presbyopia eye drop, YUVEZZI, marking the first pharmacologic therapy for age‑related near‑vision loss. A Phase 3 trial demonstrated a statistically significant two‑line improvement in near visual acuity. The company simultaneously announced a $235 million financing...

By Endpoints News
Bionano Mapping Reveals Complexities of Chromosomal Duplications
NewsJan 29, 2026

Bionano Mapping Reveals Complexities of Chromosomal Duplications

Bionano Genomics announced that its latest optical mapping platform has uncovered unprecedented structural complexity within chromosomal duplications, pinpointing breakpoint architecture at kilobase resolution. The study, involving over 200 patient genomes, revealed that many duplications comprise nested inversions, insertions, and micro‑homology...

By Bioengineer.org
Postmortem CT Vs. Autopsy: Fracture Detection Compared
NewsJan 29, 2026

Postmortem CT Vs. Autopsy: Fracture Detection Compared

A new meta‑analysis in the International Journal of Legal Medicine compares postmortem computed tomography (PMCT) with traditional autopsy for fracture detection across dozens of forensic cases. The study finds PMCT identifies roughly 15% more minor fractures and achieves a 92%...

By Bioengineer.org
Blood Glucose Monitoring
BlogJan 29, 2026

Blood Glucose Monitoring

The episode explores how AI and machine learning are reshaping blood glucose monitoring, moving from invasive blood draws toward non‑invasive analysis of sweat, saliva, and interstitial fluid. It highlights advances such as Raman spectroscopy combined with AI to interpret complex...

By Metaphysical Cells
Tissue Engineering
PodcastJan 29, 20261 min

Tissue Engineering

The winners from NASA’s Vascular Tissue Challenge are taking their Earth-based research to space.

By Innovation Now
Engineered Hydrogel Scaffolds Create Stable Microvasculature
NewsJan 29, 2026

Engineered Hydrogel Scaffolds Create Stable Microvasculature

Researchers have engineered a hydrogel scaffold that supports the formation of stable, perfusable microvasculature in vitro. By fine‑tuning matrix stiffness and incorporating angiogenic cues, endothelial cells self‑assemble into lumenized networks that persist for weeks. The platform demonstrated consistent blood‑like flow...

By Bioengineer.org
Five-Year Study: Analyzing Factors Behind Patient Falls
NewsJan 29, 2026

Five-Year Study: Analyzing Factors Behind Patient Falls

A comprehensive five‑year, multi‑center study has identified the primary drivers of patient falls in acute care settings. Researchers analyzed over 200,000 admissions, linking fall incidence to age, medication adjustments, staffing patterns, and environmental hazards. The data reveal that patients older...

By Bioengineer.org
Brain Organoids Map How Distinct Autism Mutations Converge in Early Development
NewsJan 29, 2026

Brain Organoids Map How Distinct Autism Mutations Converge in Early Development

Researchers used human induced pluripotent stem cell‑derived brain organoids to map the impact of eight autism‑linked genetic mutations. RNA‑seq across four developmental stages showed that early distinct molecular signatures gradually converge on shared pathways governing neuronal maturation and synapse formation....

By GEN (Genetic Engineering & Biotechnology News)
Tumour Macrophage States Linked to Unique lncRNAs in Lung Cancer
NewsJan 29, 2026

Tumour Macrophage States Linked to Unique lncRNAs in Lung Cancer

A new study in *Genes & Immunity* maps long non‑coding RNAs (lncRNAs) that define tumor‑associated macrophage (TAM) states in lung cancer, revealing stark differences between murine and human TAM transcriptomes. The researchers found only a handful of conserved lncRNAs, with...

By Bioengineer.org
Team Achieves Safe Age‑Reversal Breakthrough at LiFE BIOSCIENCES
SocialJan 29, 2026

Team Achieves Safe Age‑Reversal Breakthrough at LiFE BIOSCIENCES

Meet the LiFE BIOSCIENCES team, from L to R, Dr. Michael Ringel (COO), Dr. Sharon Rosenzweig-Lipson, (CSO) and Jerry McLaughlin (CEO). Not pictured Amit Shashank (CAO) and my co-founder and founding CEO, Tristan Edwards. A shout out to my lab...

By David Sinclair
How IFN Signaling Tunes Macrophage Mitochondria in Inflammation Resolution
NewsJan 29, 2026

How IFN Signaling Tunes Macrophage Mitochondria in Inflammation Resolution

A preclinical study at Spain’s CNIC revealed that type‑I interferon (IFN‑I) reprograms macrophage mitochondria through the ISG15 protein. IFN‑I binding to IFNAR lowers mitochondrial membrane potential while paradoxically increasing ATP output, prompting mitochondrial fission. These metabolic shifts boost efferocytosis, accelerating...

By GEN (Genetic Engineering & Biotechnology News)
2026 Catalysts: The Rise of RNAi
NewsJan 29, 2026

2026 Catalysts: The Rise of RNAi

RNA‑interference (RNAi) therapies are moving from experimental to mainstream, with dozens of antisense and siRNA programs slated for pivotal data releases and regulatory decisions in 2026. The year’s catalyst slate includes proof‑of‑concept readouts in novel disease areas and first‑in‑class approvals...

By BioCentury
Changes in Cardiff’s C-Suite Amid Late-Stage Push for Cancer Candidate
NewsJan 29, 2026

Changes in Cardiff’s C-Suite Amid Late-Stage Push for Cancer Candidate

Cardiff Oncology announced a reshuffle of its senior leadership as it accelerates a late‑stage oncology candidate toward market. James Whitaker, formerly a commercial head at AstraZeneca, will replace outgoing CEO Sarah Liu, while CFO Mark Patel steps down and the...

By BioCentury
PredIG: A Clear Predictor for T-Cell Epitope Immunogenicity
NewsJan 29, 2026

PredIG: A Clear Predictor for T-Cell Epitope Immunogenicity

Researchers introduced PredIG, an interpretable machine‑learning platform that predicts T‑cell epitope immunogenicity with higher accuracy than existing tools. The model integrates peptide sequence, structural conformation, and immune‑environment context, and was validated across multiple independent cohorts. By revealing the biological drivers...

By Bioengineer.org
How Prenatal Viral Infections Shape Immunity
NewsJan 29, 2026

How Prenatal Viral Infections Shape Immunity

Recent research reveals that viral infections during pregnancy can rewire the developing immune system of the fetus, leading to lasting changes in immune cell composition and function. Studies show that the timing and type of maternal infection dictate whether offspring...

By Bioengineer.org
Quantum Algorithms Achieve Lower Resource Needs for ATP/Metaphosphate Hydrolysis
BlogJan 29, 2026

Quantum Algorithms Achieve Lower Resource Needs for ATP/Metaphosphate Hydrolysis

Researchers led by Ryan LaRose, Alan Bidart, and Ben DalFavero quantified quantum resource needs for simulating ATP/metaphosphate hydrolysis. They compared eigensolver, Krylov, and phase‑estimation methods, showing heuristic approaches can run on NISQ, MegaQuop, and fault‑tolerant devices. The study introduced Hamiltonian...

By Quantum Zeitgeist
China’s Orphan Drug Exclusivity Could Bolster Market, Incentivize Development
NewsJan 29, 2026

China’s Orphan Drug Exclusivity Could Bolster Market, Incentivize Development

Effective May 15, China will grant orphan drugs a seven‑year market exclusivity and provide a two‑year exclusivity period for pediatric indications. The legislation also enshrines accelerated approval pathways—breakthrough, conditional, and priority review—into national law, reducing regulatory uncertainty. While many implementation details...

By BioCentury
Biomimetic Vesicles Engineered From Modified Tumour Cells Act as Personalized Vaccines for Post-Surgical Cancer Immunotherapy
NewsJan 29, 2026

Biomimetic Vesicles Engineered From Modified Tumour Cells Act as Personalized Vaccines for Post-Surgical Cancer Immunotherapy

Researchers engineered tumor cells to overexpress STX11, converting them into dendritic‑cell‑like antigen‑presenting units. Membrane fragments from these cells were fused with PLGA nanoparticles carrying a TLR7 agonist, creating RP@SMs vesicles that act as personalized post‑surgical cancer vaccines. The platform demonstrated...

By Nature Nanotechnology
Pediatric Pseudotumor Cerebri: Apelin Isoforms and Oxidative Stress
NewsJan 28, 2026

Pediatric Pseudotumor Cerebri: Apelin Isoforms and Oxidative Stress

Researchers published the first molecular profiling of pediatric pseudotumor cerebri, revealing altered apelin isoform levels and heightened oxidative stress in affected children. By comparing cerebrospinal fluid and serum samples to healthy controls, the study linked these biochemical changes to symptom...

By Bioengineer.org
ChenMed CEO Warns Against GLP-1s for Seniors
NewsJan 28, 2026

ChenMed CEO Warns Against GLP-1s for Seniors

ChenMed chief executive Chris Chen announced that the senior‑focused primary‑care network will stop encouraging the use of GLP‑1 drugs such as Ozempic and Wegovy for weight‑loss purposes. The decision follows internal data linking these medications to higher rates of dehydration,...

By Endpoints News
Health Expenditure Trends in Mainland China: 2012-2020
NewsJan 28, 2026

Health Expenditure Trends in Mainland China: 2012-2020

China’s total health expenditure rose sharply from roughly 5.2% of GDP in 2012 to 7.1% in 2020, marking a compound annual growth rate of about 6.5%. Government spending accounted for nearly half of the increase, while private out‑of‑pocket payments fell...

By Bioengineer.org
Chris Petty Advances Cell Age Reset, ER‑100 Trials Near
SocialJan 28, 2026

Chris Petty Advances Cell Age Reset, ER‑100 Trials Near

PhD student Chris Petty presents his latest results to the lab. His project is to uncover the mystery of how it’s possible to reset the age of a cell. Where does the back up lie? It’s one of the biggest...

By David Sinclair
Biodegradable Graphene Sensors Made From Agripapers
NewsJan 28, 2026

Biodegradable Graphene Sensors Made From Agripapers

Researchers at XYZ University have unveiled a new class of biodegradable sensors that combine graphene with agripaper—a paper made from agricultural residues. The devices demonstrate up to 95% of the sensitivity of conventional graphene sensors while fully decomposing in compost...

By Bioengineer.org
There Are No Silver Bullets in China
BlogJan 28, 2026

There Are No Silver Bullets in China

Oncology innovation in China is shifting from fast‑follow biosimilars to globally competitive, next‑generation modalities, as revealed at the recent JP Morgan Healthcare conference. The momentum is driven primarily by emerging biotech firms in East Asia rather than the region’s traditional Big‑3...

By Biotech Strategy Blog
Sperm DNA Fragmentation: Impact on Mammalian Reproduction
NewsJan 28, 2026

Sperm DNA Fragmentation: Impact on Mammalian Reproduction

Recent studies reveal that sperm DNA fragmentation (SDF) significantly impairs mammalian reproductive outcomes, lowering fertilization rates and embryo quality. Researchers attribute elevated SDF to oxidative stress, environmental toxins, and advancing male age, prompting a surge in diagnostic testing. Clinical trials...

By Bioengineer.org
Round Three of IRA Negotiations Is Expected to Be ‘Manageable’ for Pharma
NewsJan 28, 2026

Round Three of IRA Negotiations Is Expected to Be ‘Manageable’ for Pharma

Analysts say the third round of Medicare drug‑price negotiations under the Inflation Reduction Act will be largely manageable for large pharmaceutical firms. The round focuses on a limited set of high‑cost specialty medicines, with negotiations slated to begin in 2025....

By Endpoints News
Nautilus, Weill Cornell Team Up to Apply Single Molecule Proteomics Tech to Parkinson’s
NewsJan 28, 2026

Nautilus, Weill Cornell Team Up to Apply Single Molecule Proteomics Tech to Parkinson’s

Nautilus and Weill Cornell Medicine‑Qatar have secured $1.6 million from the Michael J. Fox Foundation to develop a single‑molecule proteomics assay for alpha‑synuclein proteoforms in Parkinson’s disease. The collaboration merges Hilal Lashuel’s expertise in alpha‑synuclein post‑translational modifications with Nautilus’s Iterative Mapping...

By GEN (Genetic Engineering & Biotechnology News)
Gut Bacteria Lysogeny Alters Genome Profiles Significantly
NewsJan 28, 2026

Gut Bacteria Lysogeny Alters Genome Profiles Significantly

Researchers led by K. Pick and T.L. Raivio applied transcriptomic profiling to a lysogenic Escherichia coli strain cultured in simulated intestinal fluid. Integrated bacteriophage DNA caused extensive changes in both core and accessory gene expression, notably affecting virulence and metabolic...

By Bioengineer.org
Unprecedented 3D Views of Sensory Cells Accelerate Hearing Research
NewsJan 28, 2026

Unprecedented 3D Views of Sensory Cells Accelerate Hearing Research

University of California San Diego researchers unveiled Vision Analysis StereoCilia (VASCilia), an AI‑driven tool that creates high‑resolution 3D visualizations of cochlear hair‑cell stereocilia. By applying five deep‑learning models, VASCilia accelerates image analysis by roughly 50‑fold compared with manual methods. The...

By Phys.org – Biotechnology
PlasmoBridge Chip Enables Ultrasensitive and Rapid Monitoring of Methotrexate
NewsJan 28, 2026

PlasmoBridge Chip Enables Ultrasensitive and Rapid Monitoring of Methotrexate

Researchers at the Chinese Academy of Sciences unveiled PlasmoBridge, a dual‑functional sensor chip that uses aptamer‑linked silver nanoparticles to generate plasmonic hotspots for methotrexate detection. The platform achieves a limit of detection of 4.64 × 10⁻⁸ M and, with a convolutional neural network,...

By Phys.org – Nanotechnology
Complete Human Genome Tandem Repeat Catalog Released
NewsJan 28, 2026

Complete Human Genome Tandem Repeat Catalog Released

An international consortium has released the first comprehensive catalog of tandem repeats across the entire human genome, covering more than one million loci. The database provides detailed repeat length distributions, population allele frequencies from over 100,000 sequenced genomes, and functional...

By Bioengineer.org
FDA Asks Court to Pause Louisiana's Abortion Pill Fight
NewsJan 28, 2026

FDA Asks Court to Pause Louisiana's Abortion Pill Fight

The U.S. Justice Department, representing the Trump administration, has petitioned a federal court to suspend a Louisiana lawsuit challenging the FDA’s approval of the abortion medication mifepristone. The request comes as the FDA conducts a comprehensive safety and efficacy review...

By Endpoints News
Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine
NewsJan 28, 2026

Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine

Rare‑disease therapies have shifted from a niche experiment to a core growth engine for biopharma, driven by the 1983 Orphan Drug Act and subsequent incentives. Smaller, adaptive trials and surrogate endpoints have lowered development costs, with orphan drugs averaging about...

By Pharmaceutical Technology
Halozyme Diversifies in Drug Delivery with Surf Bio Buy
NewsJan 28, 2026

Halozyme Diversifies in Drug Delivery with Surf Bio Buy

Halozyme Therapeutics has bolstered its drug‑delivery portfolio by acquiring Surf Bio for a $300 million upfront payment, adding the ultrahigh‑concentration Snapshot platform. The deal follows a recent $750 million purchase of Elektrofi, giving Halozyme three complementary technologies for subcutaneous administration. Snapshot enables...

By pharmaphorum
Reviewing the Role of Mitochondrial Dysfunction in Alzheimer's Disease
BlogJan 28, 2026

Reviewing the Role of Mitochondrial Dysfunction in Alzheimer's Disease

Recent open‑access review argues mitochondrial dysfunction is a central driver of Alzheimer’s disease. The paper highlights altered mitochondrial morphology, reduced mtDNA, and impaired oxidative phosphorylation in AD brains. It proposes mitochondrial transplantation, delivered intrathecally, as a near‑term therapeutic strategy, while...

By Fight Aging!
Lonza Still Intends to Sell Its Capsules and Health Ingredients Business
NewsJan 28, 2026

Lonza Still Intends to Sell Its Capsules and Health Ingredients Business

Swiss CDMO Lonza reaffirmed its intention to sell its capsules and health ingredients division. The transaction, first announced more than a year ago, has not yet been finalized. Lonza cited ongoing negotiations and market conditions as reasons for the delay....

By Endpoints News
Separase’s Key Role in Nuclear Lamin Regulation
NewsJan 28, 2026

Separase’s Key Role in Nuclear Lamin Regulation

Researchers have uncovered that separase, the protease known for triggering sister‑chromatid separation, directly cleaves nuclear lamins during mitotic entry. The study demonstrates that separase-mediated lamin A/C cleavage is essential for nuclear envelope breakdown and proper chromosome segregation. Using CRISPR‑engineered human...

By Bioengineer.org
Capturing the Moment of Organelle Handoff Inside Living Cells
NewsJan 28, 2026

Capturing the Moment of Organelle Handoff Inside Living Cells

Researchers have, for the first time, directly visualized autophagosomes moving from the endoplasmic reticulum (ER) onto microtubule tracks inside living cells. By combining interferometric scattering microscopy with fluorescence labeling in a custom DySLIM platform, they captured the handoff event with...

By Phys.org – Nanotechnology
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
NewsJan 28, 2026

How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs

A looming U.S. government shutdown could cripple FDA operational capacity, turning routine inspections into a bottleneck and creating a sizable backlog of pending reviews. While user‑fee‑funded core reviews may continue, the loss of predictability hampers agency responsiveness and administrative processing....

By Pharmaceutical Technology
Long-Term Prognosis for Older Classical Hodgkin Lymphoma Patients
NewsJan 28, 2026

Long-Term Prognosis for Older Classical Hodgkin Lymphoma Patients

A recent multi‑center analysis examined long‑term outcomes for patients over 60 with classical Hodgkin lymphoma (cHL). Using modern PET‑adapted regimens, five‑year overall survival rose to roughly 70%, though treatment‑related toxicity remains a key challenge. The study highlighted the benefit of...

By Bioengineer.org
Exercise-Derived Vesicles: A Breakthrough in Cancer Therapy
NewsJan 28, 2026

Exercise-Derived Vesicles: A Breakthrough in Cancer Therapy

Researchers led by Silvestri et al. have shown that extracellular vesicles released during physical exercise carry proteins, lipids and RNA that can influence tumor biology. The study demonstrates that these exercise‑derived EVs can boost immune recognition of cancer cells and...

By Bioengineer.org
Key Factors in Cardiovascular Care Delivery
NewsJan 28, 2026

Key Factors in Cardiovascular Care Delivery

A new BMC Health Services Research study by Durmuş and Akbolat maps the expectations of cardiovascular patients across clinical, interpersonal, environmental, digital, and demographic dimensions. The research reveals that empathy, provider competence, and a welcoming care environment are as critical...

By Bioengineer.org
Advanced TadA Editors Enable Precise Disease Variant Modeling
NewsJan 28, 2026

Advanced TadA Editors Enable Precise Disease Variant Modeling

Researchers have unveiled next‑generation TadA‑based adenine base editors that achieve near‑perfect A‑to‑G conversion at disease‑relevant loci. The editors demonstrate editing efficiencies up to 95% with off‑target rates below 0.1%, and have been used to generate more than 30 pathogenic point...

By Bioengineer.org
FDA Guidance Clears Path for Wearable Wellness Claims
SocialJan 28, 2026

FDA Guidance Clears Path for Wearable Wellness Claims

An inventive new guidance from @US_FDA, opens opportunities for wellness claims for wearable devices like blood pressure. Enables innovation that empowers consumers and providers, and creates avenues for technology-enabled, high-access primary care. https://t.co/sxmD1DNkNW

By Scott Gottlieb
Teva CEO Says It Has Successfully Transitioned Into a Biopharma Company
NewsJan 28, 2026

Teva CEO Says It Has Successfully Transitioned Into a Biopharma Company

Teva Pharmaceutical Industries announced that its latest earnings demonstrate a completed shift from a pure‑play generics manufacturer to a biopharma‑focused enterprise. The CEO highlighted that revenue from specialty and branded products now exceeds traditional generic sales, confirming the strategic pivot....

By Endpoints News